ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,431.60
-0.04%
US Tech 100
19,168.00
0.52%
다우존스 지수
38,589.16
-0.15%
Bitcoin
66,270.39
0.12%
Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Puma Biotechnology Inc (PBYI)

  7. Puma Biotechnology Inc (PBYI) 뉴스

PBYI

Puma Biotechnology (PBYI)

Puma Biotechnology Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:PBYI
일자시간출처헤드라인심볼기업
2024/06/1410:46Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PBYIPuma Biotechnology Inc
2024/06/1410:44Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PBYIPuma Biotechnology Inc
2024/06/1410:43Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PBYIPuma Biotechnology Inc
2024/06/1410:41Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PBYIPuma Biotechnology Inc
2024/06/0806:37Business WirePuma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:PBYIPuma Biotechnology Inc
2024/06/0403:33Business WirePuma Biotechnology Announces Presentation of Findings from a Phase I/Ib Study of Alisertib in Advanced EGFR-Mutated Lung CancerNASDAQ:PBYIPuma Biotechnology Inc
2024/06/0223:01Business WirePuma Biotechnology Announces Presentation of Findings from a Phase II Study of Alisertib in Endocrine-Resistant Metastatic Breast Cancer (TBCRC 041)NASDAQ:PBYIPuma Biotechnology Inc
2024/05/2822:00Business WirePuma Biotechnology to Join Russell 3000 IndexNASDAQ:PBYIPuma Biotechnology Inc
2024/05/2406:15Business WirePuma Biotechnology Announces Publication of Alisertib Abstract Titles for the 2024 ASCO Annual MeetingNASDAQ:PBYIPuma Biotechnology Inc
2024/05/1805:43Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PBYIPuma Biotechnology Inc
2024/05/0305:05Business WirePuma Biotechnology Reports First Quarter Financial ResultsNASDAQ:PBYIPuma Biotechnology Inc
2024/04/1905:15Business WirePuma Biotechnology to Host Conference Call to Discuss First Quarter 2024 Financial ResultsNASDAQ:PBYIPuma Biotechnology Inc
2024/04/0406:30Business WirePuma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:PBYIPuma Biotechnology Inc
2024/03/2021:30Business WirePuma Biotechnology Announces FDA Allowance to Proceed Under IND for Alisertib in HER2-Negative, Hormone Receptor-Positive Metastatic Breast CancerNASDAQ:PBYIPuma Biotechnology Inc
2024/03/0106:16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PBYIPuma Biotechnology Inc
2024/03/0106:05Business WirePuma Biotechnology Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:PBYIPuma Biotechnology Inc
2024/02/2808:30Business WirePuma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:PBYIPuma Biotechnology Inc
2024/02/2306:10Business WirePuma Biotechnology to Participate in a Panel Discussion at TD Cowen’s 44th Annual Health Care ConferenceNASDAQ:PBYIPuma Biotechnology Inc
2024/02/1606:10Business WirePuma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:PBYIPuma Biotechnology Inc
2024/02/1508:03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PBYIPuma Biotechnology Inc
2024/02/1508:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PBYIPuma Biotechnology Inc
2024/02/1508:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PBYIPuma Biotechnology Inc
2024/02/1507:54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PBYIPuma Biotechnology Inc
2024/02/1422:19Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:PBYIPuma Biotechnology Inc
2024/02/1322:30Business WirePuma Biotechnology Announces Initiation of ALISCA-Lung1 Phase II Trial of Alisertib in Small Cell Lung CancerNASDAQ:PBYIPuma Biotechnology Inc
2024/02/0705:54Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:PBYIPuma Biotechnology Inc
2024/01/1823:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PBYIPuma Biotechnology Inc
2024/01/1206:07Business WirePuma Biotechnology to Present at B. Riley Securities 4th Annual Oncology ConferenceNASDAQ:PBYIPuma Biotechnology Inc
2024/01/1106:41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PBYIPuma Biotechnology Inc
2024/01/1106:38Edgar (US Regulatory)Form 144/A - Report of proposed sale of securities: [Amend]NASDAQ:PBYIPuma Biotechnology Inc
 검색 관련기사 보기:NASDAQ:PBYI

최근 히스토리

NASDAQ
NVDA
NVIDIA
AMEX
SPY
SPDR S&P 500
NYSE
XOM
Exxon Mobil
USOTC
BASFY
BASF (QX)
USOTC
ADDYY
Adidas (QX)
AMEX
XLV
Health Care Select Sector
NASDAQ
TSLA
Tesla
USOTC
RHHBY
Roche (QX)
FX
USDEUR
US Dollar vs Euro
NASDAQ
QQQ
Invesco QQQ Trust Series 1
USOTC
DTEGY
Deutsche Telekom (QX)
AMEX
XLF
Financial Select Sector
AMEX
XLE
Energy Select Sector SPDR
NYSE
MCD
McDonalds
PM
XAUUSD
Gold vs US Dollar
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유